speb/financial-data huggingface dataset:
CHCI cash_flow (annual, 2024-12-31) — Net Investment Properties Purchase And Sale: 446000.00
CHCI cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -428000.00
CHCI income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 672000.00
CHCI cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -578000.00
CHCI balance_sheet (annual, 2024-12-31) — Net PPE: 6550000.00
CHCI cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -368000.00
CHCI balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 52225000.00
CHCI balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 15158000.00
CHCI balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 492000.00
CHCI balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 14720000.00
CHCI income_statement (annual, 2024-12-31) — Normalized EBITDA: 10886000.00
CHCI income_statement (annual, 2024-12-31) — Normalized Income: 14794630.00
CHCI cash_flow (annual, 2024-12-31) — Operating Cash Flow: 10675000.00
CHCI cash_flow (annual, 2024-12-31) — Operating Gains Losses: 300000.00
CHCI income_statement (annual, 2024-12-31) — Operating Income: 10287000.00
CHCI income_statement (annual, 2024-12-31) — Operating Revenue: 51294000.00
CHCI balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 9909000.00
CHCI balance_sheet (annual, 2024-12-31) — Other Current Assets: 430000.00
CHCI income_statement (annual, 2024-12-31) — Other Income Expense: -234000.00
CHCI balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 144000.00
CHCI balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 144000.00
CHCI cash_flow (annual, 2024-12-31) — Other Non Cash Items: -70000.00
CHCI balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 60000.00
CHCI income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 63000.00
CHCI balance_sheet (annual, 2024-12-31) — Other Properties: 5916000.00
CHCI balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 781000.00
CHCI cash_flow (annual, 2024-12-31) — Pension And Employee Benefit Expense: 3000.00
CHCI balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 4952000.00
CHCI income_statement (annual, 2024-12-31) — Pretax Income: 10725000.00
CHCI cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 226000.00
CHCI balance_sheet (annual, 2024-12-31) — Properties: 0.00
CHCI cash_flow (annual, 2024-12-31) — Purchase Of Investment: -428000.00
CHCI cash_flow (annual, 2024-12-31) — Purchase Of Investment Properties: -140000.00
CHCI cash_flow (annual, 2024-12-31) — Purchase Of PPE: -368000.00
CHCI balance_sheet (annual, 2024-12-31) — Receivables: 7536000.00
CHCI income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 38630000.00
CHCI income_statement (annual, 2024-12-31) — Reconciled Depreciation: 302000.00
CHCI balance_sheet (annual, 2024-12-31) — Retained Earnings: -147770000.00
CHCI cash_flow (annual, 2024-12-31) — Sale Of Investment: 0.00
CHCI cash_flow (annual, 2024-12-31) — Sale Of Investment Properties: 586000.00
CHCI income_statement (annual, 2024-12-31) — Selling General And Administration: 2075000.00
CHCI balance_sheet (annual, 2024-12-31) — Share Issued: 9995000.00
CHCI cash_flow (annual, 2024-12-31) — Stock Based Compensation: 945000.00
CHCI balance_sheet (annual, 2024-12-31) — Stockholders Equity: 52369000.00
CHCI balance_sheet (annual, 2024-12-31) — Tangible Book Value: 52225000.00
CHCI income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -62370.00
CHCI income_statement (annual, 2024-12-31) — Tax Provision: -3835000.00
CHCI income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
CHCI balance_sheet (annual, 2024-12-31) — Total Assets: 64867000.00
CHCI balance_sheet (annual, 2024-12-31) — Total Capitalization: 52369000.00
CHCI balance_sheet (annual, 2024-12-31) — Total Debt: 6273000.00
CHCI balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 52369000.00
CHCI income_statement (annual, 2024-12-31) — Total Expenses: 41007000.00
CHCI balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 12498000.00
CHCI balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 28140000.00
CHCI balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 5843000.00
CHCI income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 10287000.00
CHCI income_statement (annual, 2024-12-31) — Total Unusual Items: -297000.00
CHCI income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -297000.00
CHCI balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 86000.00
CHCI balance_sheet (quarterly, 2024-12-31) — Treasury Shares Number: 86000.00
CHCI balance_sheet (annual, 2024-12-31) — Treasury Stock: 2662000.00
CHCI balance_sheet (annual, 2024-12-31) — Working Capital: 30072000.00
CHCI income_statement (quarterly, 2025-03-31) — +Operating Expense: 615000.00
CHCI income_statement (quarterly, 2025-03-31) — +Total Revenue: 12639000.00
CHCI balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 1090000.00
CHCI balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 433000.00
CHCI balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 202460000.00
CHCI income_statement (quarterly, 2025-03-31) — Basic Average Shares: 10033000.00
CHCI income_statement (quarterly, 2025-03-31) — Basic EPS: 0.16
CHCI cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 28761000.00
CHCI cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -163000.00
CHCI balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 6047000.00
CHCI balance_sheet (quarterly, 2025-03-31) — Capital Stock: 100000.00
CHCI balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 28297000.00
CHCI balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 28297000.00
CHCI cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -39000.00
CHCI cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -492000.00
CHCI cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -515000.00
CHCI cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 543000.00
CHCI cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 310000.00
CHCI cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -3717000.00
CHCI cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 253000.00
CHCI cash_flow (quarterly, 2025-03-31) — Change In Payable: 310000.00
CHCI cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -3407000.00
CHCI cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -167000.00
CHCI cash_flow (quarterly, 2025-03-31) — Change In Receivables: 1690000.00
CHCI cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -1631000.00
CHCI cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 1690000.00
CHCI cash_flow (quarterly, 2025-03-31) — Changes In Cash: -464000.00
CHCI balance_sheet (quarterly, 2025-03-31) — Common Stock: 100000.00
CHCI cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -39000.00
CHCI balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 53717000.00
CHCI cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 86000.00
CHCI income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 10287000.00
CHCI balance_sheet (quarterly, 2025-03-31) — Current Assets: 34805000.00
CHCI balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 940000.00
CHCI balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 940000.00
CHCI balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 3265000.00
CHCI cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 323000.00
CHCI cash_flow (quarterly, 2025-03-31) — Deferred Tax: 323000.00
CHCI cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 80000.00
CHCI income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 80000.00
CHCI cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 80000.00
CHCI income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 80000.00
CHCI income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 10367000.00
CHCI income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.15
CHCI income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 1589000.00
CHCI cash_flow (quarterly, 2025-03-31) — Dividends Received Cfi: 1000.00
CHCI balance_sheet (quarterly, 2025-03-31) — Duefrom Related Parties Current: 5413000.00
CHCI income_statement (quarterly, 2025-03-31) — EBIT: 1737000.00
CHCI income_statement (quarterly, 2025-03-31) — EBITDA: 1817000.00
CHCI cash_flow (quarterly, 2025-03-31) — End Cash Position: 28297000.00
CHCI cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -492000.00
CHCI cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 380000.00
CHCI cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: -9000.00
CHCI income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 9000.00
CHCI balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 144000.00
CHCI balance_sheet (quarterly, 2025-03-31) — Gross PPE: 6408000.00
CHCI income_statement (quarterly, 2025-03-31) — Gross Profit: 2352000.00
CHCI cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 0.00
CHCI income_statement (quarterly, 2025-03-31) — Interest Income: 184000.00
CHCI income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 184000.00
CHCI cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 188000.00
CHCI balance_sheet (quarterly, 2025-03-31) — Invested Capital: 53717000.00
CHCI cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -515000.00
CHCI balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 6248000.00
CHCI balance_sheet (quarterly, 2025-03-31) — Investments In Other Ventures Under Equity Method: 6248000.00
CHCI cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 86000.00
CHCI balance_sheet (quarterly, 2025-03-31) — Leases: 52000.00
CHCI balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 5107000.00
CHCI balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 5107000.00
CHCI balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 6248000.00
CHCI cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 86000.00
CHCI income_statement (quarterly, 2025-03-31) — Net Income: 1589000.00
CHCI income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 1589000.00
CHCI income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 1589000.00
CHCI income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 1589000.00
CHCI income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 1589000.00
CHCI cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 1589000.00
CHCI income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 1589000.00
CHCI income_statement (quarterly, 2025-03-31) — Net Interest Income: 184000.00
CHCI cash_flow (quarterly, 2025-03-31) — Net Investment Properties Purchase And Sale: -7000.00
CHCI cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -346000.00
CHCI income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 184000.00
CHCI cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -578000.00
CHCI balance_sheet (quarterly, 2025-03-31) — Net PPE: 6408000.00
CHCI cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -163000.00
CHCI balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 53573000.00
CHCI balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 15147000.00
CHCI balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 718000.00
CHCI balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 14397000.00
CHCI income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 1808000.00
CHCI income_statement (quarterly, 2025-03-31) — Normalized Income: 1581520.40
CHCI cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 543000.00
CHCI cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -4000.00
CHCI income_statement (quarterly, 2025-03-31) — Operating Income: 1737000.00
CHCI income_statement (quarterly, 2025-03-31) — Operating Revenue: 12639000.00
CHCI balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 10068250.00
CHCI balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 662000.00
CHCI income_statement (quarterly, 2025-03-31) — Other Income Expense: -9000.00
CHCI balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 144000.00
CHCI cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -65000.00
CHCI balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 55000.00
CHCI income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -18000.00
CHCI balance_sheet (quarterly, 2025-03-31) — Other Properties: 6356000.00
CHCI balance_sheet (quarterly, 2025-03-31) — Payables: 1090000.00
CHCI balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 1090000.00
CHCI cash_flow (quarterly, 2025-03-31) — Pension And Employee Benefit Expense: 5000.00
CHCI balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 1235000.00
CHCI income_statement (quarterly, 2025-03-31) — Pretax Income: 1912000.00
CHCI balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
CHCI cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -346000.00
CHCI cash_flow (quarterly, 2025-03-31) — Purchase Of Investment Properties: -7000.00
CHCI cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -163000.00
CHCI balance_sheet (quarterly, 2025-03-31) — Receivables: 5846000.00
CHCI income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 10287000.00
CHCI income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 80000.00
CHCI balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -146181000.00
CHCI cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 0.00
CHCI income_statement (quarterly, 2025-03-31) — Selling General And Administration: 535000.00
CHCI balance_sheet (quarterly, 2025-03-31) — Share Issued: 10154250.00
CHCI cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 251000.00
CHCI balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 53717000.00
CHCI balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 53573000.00
CHCI income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 1520.40
CHCI income_statement (quarterly, 2025-03-31) — Tax Provision: 323000.00
CHCI income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.17
CHCI balance_sheet (quarterly, 2025-03-31) — Total Assets: 62807000.00
CHCI balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 53717000.00
CHCI balance_sheet (quarterly, 2025-03-31) — Total Debt: 6047000.00
CHCI balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 53717000.00
CHCI income_statement (quarterly, 2025-03-31) — Total Expenses: 10902000.00
CHCI balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 9090000.00
CHCI balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 28002000.00
CHCI balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 5825000.00
CHCI income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 1737000.00
CHCI income_statement (quarterly, 2025-03-31) — Total Unusual Items: 9000.00
CHCI income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 9000.00
CHCI balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 86000.00
CHCI balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 2662000.00
CHCI balance_sheet (quarterly, 2025-03-31) — Working Capital: 31540000.00
CHCI income_statement (quarterly, 2025-06-30) — +Operating Expense: 687000.00
CHCI income_statement (quarterly, 2025-06-30) — +Total Revenue: 12972000.00
CHCI balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 889000.00
CHCI balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 694000.00
CHCI balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 202748000.00
CHCI income_statement (quarterly, 2025-06-30) — Basic Average Shares: 10069000.00
CHCI income_statement (quarterly, 2025-06-30) — Basic EPS: 0.14
CHCI cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 28297000.00
CHCI cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -26000.00
CHCI balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 5818000.00
CHCI balance_sheet (quarterly, 2025-06-30) — Capital Stock: 100000.00
CHCI balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 30483000.00
CHCI balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 30483000.00
CHCI cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 0.00
CHCI cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -38000.00
CHCI cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 2224000.00
CHCI cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -202000.00
CHCI cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 1002000.00
CHCI cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -255000.00
CHCI cash_flow (quarterly, 2025-06-30) — Change In Payable: -202000.00
CHCI cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 800000.00
CHCI cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -249000.00
CHCI cash_flow (quarterly, 2025-06-30) — Change In Receivables: -816000.00
CHCI cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -215000.00
CHCI cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -816000.00
CHCI cash_flow (quarterly, 2025-06-30) — Changes In Cash: 2186000.00
CHCI balance_sheet (quarterly, 2025-06-30) — Common Stock: 100000.00
CHCI balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 55451000.00
CHCI income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 10502000.00
CHCI balance_sheet (quarterly, 2025-06-30) — Current Assets: 38064000.00
CHCI balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 957000.00
CHCI balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 957000.00
CHCI balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 4083000.00
CHCI cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 639000.00
CHCI cash_flow (quarterly, 2025-06-30) — Deferred Tax: 639000.00
CHCI cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 78000.00
CHCI income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 78000.00
CHCI cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 78000.00
CHCI income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 78000.00
CHCI income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 10436000.00
CHCI income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.14
CHCI income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 1446000.00
CHCI cash_flow (quarterly, 2025-06-30) — Dividends Received Cfi: 1000.00
CHCI balance_sheet (quarterly, 2025-06-30) — Duefrom Related Parties Current: 5968000.00
CHCI income_statement (quarterly, 2025-06-30) — EBIT: 1783000.00
CHCI income_statement (quarterly, 2025-06-30) — EBITDA: 1861000.00
CHCI cash_flow (quarterly, 2025-06-30) — End Cash Position: 30483000.00
CHCI cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 0.00
CHCI cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 2198000.00
CHCI income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 9000.00
CHCI balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 144000.00
CHCI balance_sheet (quarterly, 2025-06-30) — Gross PPE: 6127000.00
CHCI income_statement (quarterly, 2025-06-30) — Gross Profit: 2470000.00
CHCI cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 0.00
CHCI income_statement (quarterly, 2025-06-30) — Interest Income: 220000.00
CHCI income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 220000.00
CHCI balance_sheet (quarterly, 2025-06-30) — Invested Capital: 55451000.00
CHCI cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -38000.00
CHCI balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 6266000.00
CHCI balance_sheet (quarterly, 2025-06-30) — Investments In Other Ventures Under Equity Method: 6266000.00
CHCI balance_sheet (quarterly, 2025-06-30) — Leases: 45000.00
CHCI balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 4861000.00
CHCI balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 4861000.00
CHCI balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 6266000.00
CHCI income_statement (quarterly, 2025-06-30) — Net Income: 1446000.00
CHCI income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 1446000.00
CHCI income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 1446000.00
CHCI income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 1446000.00
CHCI income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 1446000.00
CHCI cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 1446000.00
CHCI income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 1446000.00
CHCI income_statement (quarterly, 2025-06-30) — Net Interest Income: 220000.00
CHCI cash_flow (quarterly, 2025-06-30) — Net Investment Properties Purchase And Sale: -3000.00
CHCI cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -10000.00
CHCI income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 220000.00
CHCI cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: 0.00
CHCI balance_sheet (quarterly, 2025-06-30) — Net PPE: 6127000.00
CHCI cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -26000.00
CHCI balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 55307000.00
CHCI balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 14591000.00
CHCI balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 845000.00
CHCI balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 13758000.00
CHCI income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 1852000.00
CHCI income_statement (quarterly, 2025-06-30) — Normalized Income: 1439758.27
CHCI cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 2224000.00
CHCI cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -4000.00
CHCI income_statement (quarterly, 2025-06-30) — Operating Income: 1783000.00
CHCI income_statement (quarterly, 2025-06-30) — Operating Revenue: 12972000.00
CHCI balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 10068250.00
CHCI balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 919000.00
CHCI income_statement (quarterly, 2025-06-30) — Other Income Expense: 82000.00
CHCI balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 144000.00
CHCI cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -8000.00
CHCI balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 48000.00
CHCI income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 73000.00
CHCI balance_sheet (quarterly, 2025-06-30) — Other Properties: 6082000.00
CHCI balance_sheet (quarterly, 2025-06-30) — Payables: 889000.00
CHCI balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 889000.00
CHCI cash_flow (quarterly, 2025-06-30) — Pension And Employee Benefit Expense: 3000.00
CHCI balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 2237000.00
CHCI income_statement (quarterly, 2025-06-30) — Pretax Income: 2085000.00
CHCI balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
CHCI cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -51000.00
CHCI cash_flow (quarterly, 2025-06-30) — Purchase Of Investment Properties: -3000.00
CHCI cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -26000.00
CHCI balance_sheet (quarterly, 2025-06-30) — Receivables: 6662000.00
CHCI income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 10502000.00
CHCI income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 78000.00
CHCI balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -144735000.00
CHCI cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 41000.00
CHCI income_statement (quarterly, 2025-06-30) — Selling General And Administration: 609000.00
CHCI balance_sheet (quarterly, 2025-06-30) — Share Issued: 10156250.00
CHCI cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 288000.00
CHCI balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 55451000.00
CHCI balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 55307000.00
CHCI income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 2758.27
CHCI income_statement (quarterly, 2025-06-30) — Tax Provision: 639000.00
CHCI income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.31
CHCI balance_sheet (quarterly, 2025-06-30) — Total Assets: 65240000.00
CHCI balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 55451000.00
CHCI balance_sheet (quarterly, 2025-06-30) — Total Debt: 5818000.00
CHCI balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 55451000.00
CHCI income_statement (quarterly, 2025-06-30) — Total Expenses: 11189000.00
CHCI balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 9789000.00
CHCI balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 27176000.00
CHCI balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 5706000.00
CHCI income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 1783000.00
CHCI income_statement (quarterly, 2025-06-30) — Total Unusual Items: 9000.00
CHCI income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 9000.00
CHCI balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 86000.00
CHCI balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 2662000.00
CHCI balance_sheet (quarterly, 2025-06-30) — Working Capital: 33981000.00
CHCI income_statement (quarterly, 2025-09-30) — +Operating Expense: 798000.00
CHCI income_statement (quarterly, 2025-09-30) — +Total Revenue: 13317000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 1058000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 13000000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 203020000.00
CHCI income_statement (quarterly, 2025-09-30) — Basic Average Shares: 10076000.00
CHCI income_statement (quarterly, 2025-09-30) — Basic EPS: 0.05
CHCI cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 30483000.00
CHCI cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -35000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 5588000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Capital Stock: 100000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 26171000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 26171000.00
CHCI cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 17000.00
CHCI cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -1102000.00
CHCI cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -3227000.00
CHCI cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 169000.00
CHCI cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 1505000.00
CHCI cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 352000.00
CHCI cash_flow (quarterly, 2025-09-30) — Change In Payable: 169000.00
CHCI cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 1674000.00
CHCI cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 91000.00
CHCI cash_flow (quarterly, 2025-09-30) — Change In Receivables: -6338000.00
CHCI cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -4526000.00
CHCI cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -6338000.00
CHCI cash_flow (quarterly, 2025-09-30) — Changes In Cash: -4312000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Common Stock: 100000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 56264000.00
CHCI income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 11858000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Current Assets: 40991000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 975000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 975000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 5775000.00
CHCI cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 450000.00
CHCI cash_flow (quarterly, 2025-09-30) — Deferred Tax: 450000.00
CHCI cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 73000.00
CHCI income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 73000.00
CHCI cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 73000.00
CHCI income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 73000.00
CHCI income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 10500000.00
CHCI income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.05
CHCI income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 541000.00
CHCI cash_flow (quarterly, 2025-09-30) — Dividends Received Cfi: 0.00
CHCI income_statement (quarterly, 2025-09-30) — EBIT: 661000.00
CHCI income_statement (quarterly, 2025-09-30) — EBITDA: 734000.00
CHCI cash_flow (quarterly, 2025-09-30) — End Cash Position: 26171000.00
CHCI cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 17000.00
CHCI cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -3262000.00
CHCI cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of PPE: -33000.00
CHCI income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 35000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 144000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 13000000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Gross PPE: 5856000.00
CHCI income_statement (quarterly, 2025-09-30) — Gross Profit: 1459000.00
CHCI cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 0.00
CHCI income_statement (quarterly, 2025-09-30) — Interest Income: 218000.00
CHCI income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 218000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Invested Capital: 56264000.00
CHCI cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -1102000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 6308000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Investments In Other Ventures Under Equity Method: 6308000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Leases: 37000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 4613000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 4613000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 6308000.00
CHCI income_statement (quarterly, 2025-09-30) — Net Income: 541000.00
CHCI income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 541000.00
CHCI income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 541000.00
CHCI income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 541000.00
CHCI income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 541000.00
CHCI cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 541000.00
CHCI income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 541000.00
CHCI income_statement (quarterly, 2025-09-30) — Net Interest Income: 218000.00
CHCI cash_flow (quarterly, 2025-09-30) — Net Investment Properties Purchase And Sale: -1021000.00
CHCI cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -46000.00
CHCI income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 218000.00
CHCI cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -9000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Net PPE: 5856000.00
CHCI cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -35000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 56120000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 14233000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 943000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 13308000.00
CHCI income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 699000.00
CHCI income_statement (quarterly, 2025-09-30) — Normalized Income: 513350.00
CHCI cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -3227000.00
CHCI cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -28000.00
CHCI income_statement (quarterly, 2025-09-30) — Operating Income: 661000.00
CHCI income_statement (quarterly, 2025-09-30) — Operating Revenue: 13317000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 10087000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 1820000.00
CHCI income_statement (quarterly, 2025-09-30) — Other Income Expense: 112000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 144000.00
CHCI cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 8000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 63000.00
CHCI income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 77000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Other Properties: 5819000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Payables: 1058000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 1058000.00
CHCI cash_flow (quarterly, 2025-09-30) — Pension And Employee Benefit Expense: 5000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 3742000.00
CHCI income_statement (quarterly, 2025-09-30) — Pretax Income: 991000.00
CHCI cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 26000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
CHCI cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -46000.00
CHCI cash_flow (quarterly, 2025-09-30) — Purchase Of Investment Properties: -1021000.00
CHCI cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -35000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Receivables: 13000000.00
CHCI income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 11858000.00
CHCI income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 73000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -144194000.00
CHCI cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 0.00
CHCI income_statement (quarterly, 2025-09-30) — Selling General And Administration: 725000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Share Issued: 10173000.00
CHCI cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 255000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 56264000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 56120000.00
CHCI income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 7350.00
CHCI income_statement (quarterly, 2025-09-30) — Tax Provision: 450000.00
CHCI income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
CHCI balance_sheet (quarterly, 2025-09-30) — Total Assets: 67595000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 56264000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Total Debt: 5588000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 56264000.00
CHCI income_statement (quarterly, 2025-09-30) — Total Expenses: 12656000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 11331000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 26604000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 5556000.00
CHCI income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 661000.00
CHCI income_statement (quarterly, 2025-09-30) — Total Unusual Items: 35000.00
CHCI income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 35000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 86000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 2662000.00
CHCI balance_sheet (quarterly, 2025-09-30) — Working Capital: 35216000.00
CHCI income_statement (annual, 2025-12-31) — +Operating Expense: 2851000.00
CHCI income_statement (quarterly, 2025-12-31) — +Operating Expense: 751000.00
CHCI income_statement (annual, 2025-12-31) — +Total Revenue: 62861000.00
CHCI income_statement (quarterly, 2025-12-31) — +Total Revenue: 23933000.00
CHCI balance_sheet (annual, 2025-12-31) — Accounts Receivable: 19966000.00
CHCI balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 19966000.00
CHCI balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -464000.00
CHCI balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -464000.00
CHCI balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 203246000.00
CHCI balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 203246000.00
CHCI income_statement (annual, 2025-12-31) — Basic Average Shares: 10067000.00
CHCI income_statement (quarterly, 2025-12-31) — Basic Average Shares: 10090000.00
CHCI income_statement (annual, 2025-12-31) — Basic EPS: 1.69
CHCI income_statement (quarterly, 2025-12-31) — Basic EPS: 1.34
CHCI cash_flow (annual, 2025-12-31) — Beginning Cash Position: 28761000.00
CHCI cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 26171000.00
CHCI cash_flow (annual, 2025-12-31) — Capital Expenditure: -1629000.00
CHCI cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -1405000.00
CHCI cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -1249000.00
CHCI balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 5350000.00
CHCI balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 5350000.00
CHCI balance_sheet (annual, 2025-12-31) — Capital Stock: 101000.00
CHCI balance_sheet (quarterly, 2025-12-31) — Capital Stock: 101000.00
CHCI balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 31282000.00
CHCI balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 31282000.00
CHCI balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 31282000.00
CHCI balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 31282000.00
CHCI cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -514000.00
CHCI cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -39000.00
CHCI cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -1762000.00
CHCI cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -107000.00
CHCI cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 4797000.00
CHCI cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 5257000.00
CHCI cash_flow (annual, 2025-12-31) — Change In Account Payable: 67000.00
CHCI cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -210000.00
CHCI cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 2887000.00
CHCI cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 4097000.00
CHCI cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 344000.00
CHCI cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -6000.00
CHCI cash_flow (annual, 2025-12-31) — Change In Payable: 67000.00
CHCI cash_flow (quarterly, 2025-12-31) — Change In Payable: -210000.00
CHCI cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 2954000.00
CHCI cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 3887000.00
CHCI cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -272000.00
CHCI cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 53000.00
CHCI cash_flow (annual, 2025-12-31) — Change In Receivables: -12430000.00
CHCI cash_flow (quarterly, 2025-12-31) — Change In Receivables: -6966000.00
CHCI cash_flow (annual, 2025-12-31) — Change In Working Capital: -9404000.00
CHCI cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -3032000.00
CHCI cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -12430000.00
CHCI cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -6966000.00
CHCI cash_flow (annual, 2025-12-31) — Changes In Cash: 2521000.00
CHCI cash_flow (quarterly, 2025-12-31) — Changes In Cash: 5111000.00
CHCI balance_sheet (annual, 2025-12-31) — Common Stock: 101000.00
CHCI balance_sheet (quarterly, 2025-12-31) — Common Stock: 101000.00
CHCI balance_sheet (annual, 2025-12-31) — Common Stock Equity: 69966000.00
CHCI balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 69966000.00
CHCI income_statement (annual, 2025-12-31) — Cost Of Revenue: 48080000.00
CHCI income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 15433000.00
CHCI balance_sheet (annual, 2025-12-31) — Current Assets: 53266000.00
CHCI balance_sheet (quarterly, 2025-12-31) — Current Assets: 53266000.00
CHCI balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 994000.00
CHCI balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 994000.00
CHCI balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 994000.00
CHCI balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 994000.00
CHCI balance_sheet (annual, 2025-12-31) — Current Liabilities: 9680000.00
CHCI balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 9680000.00
CHCI cash_flow (annual, 2025-12-31) — Deferred Income Tax: -4174000.00
CHCI cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -5586000.00
CHCI cash_flow (annual, 2025-12-31) — Deferred Tax: -4174000.00
CHCI cash_flow (quarterly, 2025-12-31) — Deferred Tax: -5586000.00
CHCI cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 306000.00
CHCI cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 75000.00
CHCI income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 306000.00
CHCI income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 75000.00
CHCI cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 306000.00
CHCI cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 75000.00
CHCI income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 306000.00
CHCI income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 75000.00
CHCI income_statement (annual, 2025-12-31) — Diluted Average Shares: 10470000.00
CHCI income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 10510000.00
CHCI income_statement (annual, 2025-12-31) — Diluted EPS: 1.63
CHCI income_statement (quarterly, 2025-12-31) — Diluted EPS: 1.28
CHCI income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 17051000.00
CHCI income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 13475000.00
CHCI cash_flow (annual, 2025-12-31) — Dividend Received Cfo: 0.00
CHCI cash_flow (quarterly, 2025-12-31) — Dividend Received Cfo: 0.00
CHCI income_statement (annual, 2025-12-31) — EBIT: 11930000.00
CHCI income_statement (quarterly, 2025-12-31) — EBIT: 7749000.00
CHCI income_statement (annual, 2025-12-31) — EBITDA: 12236000.00
CHCI income_statement (quarterly, 2025-12-31) — EBITDA: 7824000.00
CHCI cash_flow (annual, 2025-12-31) — End Cash Position: 31282000.00
CHCI cash_flow (quarterly, 2025-12-31) — End Cash Position: 31282000.00
CHCI cash_flow (annual, 2025-12-31) — Financing Cash Flow: -514000.00
CHCI cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -39000.00
CHCI cash_flow (annual, 2025-12-31) — Free Cash Flow: 3168000.00
CHCI cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 3852000.00
CHCI cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: 5000.00
CHCI cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: 54000.00
CHCI income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -1000.00
CHCI income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -54000.00
CHCI balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 144000.00
CHCI balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 144000.00
CHCI balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 19966000.00
CHCI balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 19966000.00
CHCI balance_sheet (annual, 2025-12-31) — Gross PPE: 6170000.00
CHCI balance_sheet (quarterly, 2025-12-31) — Gross PPE: 6170000.00
CHCI income_statement (annual, 2025-12-31) — Gross Profit: 14781000.00
CHCI income_statement (quarterly, 2025-12-31) — Gross Profit: 8500000.00
CHCI cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 0.00
CHCI cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 0.00
CHCI income_statement (annual, 2025-12-31) — Interest Income: 807000.00
CHCI income_statement (quarterly, 2025-12-31) — Interest Income: 185000.00
CHCI income_statement (annual, 2025-12-31) — Interest Income Non Operating: 807000.00
CHCI income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 185000.00
CHCI balance_sheet (annual, 2025-12-31) — Invested Capital: 69966000.00
CHCI balance_sheet (quarterly, 2025-12-31) — Invested Capital: 69966000.00
CHCI cash_flow (annual, 2025-12-31) — Investing Cash Flow: -1762000.00
CHCI cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -107000.00
CHCI balance_sheet (annual, 2025-12-31) — Investments And Advances: 5953000.00
CHCI balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 5953000.00
CHCI balance_sheet (annual, 2025-12-31) — Leases: 30000.00
CHCI balance_sheet (quarterly, 2025-12-31) — Leases: 30000.00
CHCI balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 4356000.00
CHCI balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 4356000.00
CHCI balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 4356000.00
CHCI balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 4356000.00
CHCI balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 5953000.00
CHCI balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 5953000.00
CHCI balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 1138000.00
CHCI balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 1138000.00
CHCI income_statement (annual, 2025-12-31) — Net Income: 17051000.00
CHCI income_statement (quarterly, 2025-12-31) — Net Income: 13475000.00
CHCI income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 17051000.00
CHCI income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 13475000.00
CHCI income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 17051000.00
CHCI income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 13475000.00